Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Prescription drug commercials anger some, please others
Pharmaceutical companies are spending close to $10 billion per year on direct-to-consumer advertising in the U.S. Only the entertainment industry spends more. Is that a good thing?
California Democrats propose new corporate tax to offset Medicaid cuts
The idea was floated as part of a proposed budget for the state released by Democrats in the Senate. If passed, only the top 2% of corporations in California would be impacted. The levy would generate $5 billion to $8 billion annually for Medicaid.
Cardiology practice launches walk-in clinic in Pennsylvania
The new clinic wants to keep patients out of hospital EDs when possible and provide care at a lower cost.
Novo Nordisk partners with OpenAI to speed development of new weight loss drugs
The maker of popular GLP-1 agonists Wegovy and Ozempic said technology from OpenAI, the company behind ChatGPT, will allow it to sift through and make sense of massive datasets to identify potential new uses for its diabetes and obesity treatments.
Medicare navigation company raises $100M to improve its AI, launch new financial products
Chapter, a technology company based in New York City, said it tripled its revenue last year by filling a market niche designing technology for seniors—specifically, those who have questions about the Medicare program.

Another mammography team in hot water over image quality

The FDA is notifying patients and referrers of another breast-imaging service’s slide into noncompliance with regulatory standards for image quality.

POCUS access: Urban oases, rural deserts

Fewer than 40% of rural counties in the U.S. can offer residents any access to point-of-care ultrasound, while nearly 90% of their metropolitan counterparts have POCUS aplenty.

MRI confirmed as gold standard for pre-biopsy detection of prostate cancer—but that’s ‘not the end of the story’

A clinical trial pitting MRI against a burgeoning PET/CT technique has found the de facto defending champion better at revealing the presence of any grade of prostate cancer.

Low back imaging: All-in-one MR makes strong showing vs. added CT

Two emerging MRI techniques show promise as all-in-one imaging tests for patients with pain in and below the lower back due to changes in the sacroiliac joint.

Radiology operation loses standing to provide mammography services

The FDA is warning patients and referrers about an imaging business near the nation’s capital that has fumbled away its mammography accreditation.

IDE granted for clinical research of MRI-guided focused ultrasound

The FDA has cleared a focused-ultrasound developer to compare the safety and efficacy of acoustic energy for treating prostate cancer against the more conservative approach of active surveillance.

RSNA flagship journal soars in influence; Lancet bumps NEJM on strength of pandemic publishing

Editor David Bluemke, MD, PhD, says the journal’s rising impact factor is “representative of the fundamental importance of imaging throughout our hospitals and clinics.”

Philips picks partner for multispecialty management of lung cancer

An imaging OEM is teaming with a multi-omics diagnostics company to offer lung-cancer care teams lab data alongside radiologic findings and clinical histories.

Business Intelligence

Prescription drug commercials anger some, please others

California Democrats propose new corporate tax to offset Medicaid cuts

Cardiology practice launches walk-in clinic in Pennsylvania

Novo Nordisk partners with OpenAI to speed development of new weight loss drugs

Medicare navigation company raises $100M to improve its AI, launch new financial products